nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—Sensory disturbance—Varenicline—nicotine dependence	0.0634	0.0701	CcSEcCtD
Bupivacaine—Drug hypersensitivity—Varenicline—nicotine dependence	0.0488	0.054	CcSEcCtD
Bupivacaine—Depressed mood—Varenicline—nicotine dependence	0.044	0.0486	CcSEcCtD
Bupivacaine—Urine abnormality—Varenicline—nicotine dependence	0.0355	0.0393	CcSEcCtD
Bupivacaine—Urine analysis abnormal—Varenicline—nicotine dependence	0.0334	0.037	CcSEcCtD
Bupivacaine—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.03	0.0332	CcSEcCtD
Bupivacaine—Fungal infection—Varenicline—nicotine dependence	0.0255	0.0282	CcSEcCtD
Bupivacaine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0218	0.0241	CcSEcCtD
Bupivacaine—Leukocytosis—Varenicline—nicotine dependence	0.0209	0.0231	CcSEcCtD
Bupivacaine—Dysarthria—Varenicline—nicotine dependence	0.0208	0.023	CcSEcCtD
Bupivacaine—Blood pressure increased—Varenicline—nicotine dependence	0.0197	0.0217	CcSEcCtD
Bupivacaine—Hyperkalaemia—Varenicline—nicotine dependence	0.0193	0.0214	CcSEcCtD
Bupivacaine—Euphoric mood—Varenicline—nicotine dependence	0.0169	0.0187	CcSEcCtD
Bupivacaine—Injury—Varenicline—nicotine dependence	0.0155	0.0172	CcSEcCtD
Bupivacaine—Lethargy—Varenicline—nicotine dependence	0.0146	0.0161	CcSEcCtD
Bupivacaine—Osteoarthritis—Varenicline—nicotine dependence	0.0143	0.0158	CcSEcCtD
Bupivacaine—Urinary retention—Varenicline—nicotine dependence	0.0136	0.015	CcSEcCtD
Bupivacaine—Abdominal distension—Varenicline—nicotine dependence	0.0124	0.0137	CcSEcCtD
Bupivacaine—Dysphagia—Varenicline—nicotine dependence	0.0123	0.0136	CcSEcCtD
Bupivacaine—Infestation NOS—Varenicline—nicotine dependence	0.011	0.0122	CcSEcCtD
Bupivacaine—Infestation—Varenicline—nicotine dependence	0.011	0.0122	CcSEcCtD
Bupivacaine—Bradycardia—Varenicline—nicotine dependence	0.01	0.0111	CcSEcCtD
Bupivacaine—Hypoaesthesia—Varenicline—nicotine dependence	0.00982	0.0109	CcSEcCtD
Bupivacaine—Oedema peripheral—Varenicline—nicotine dependence	0.00972	0.0108	CcSEcCtD
Bupivacaine—Tinnitus—Varenicline—nicotine dependence	0.0092	0.0102	CcSEcCtD
Bupivacaine—Cardiac disorder—Varenicline—nicotine dependence	0.00916	0.0101	CcSEcCtD
Bupivacaine—Chills—Varenicline—nicotine dependence	0.00886	0.0098	CcSEcCtD
Bupivacaine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00885	0.0923	CbGpPWpGaD
Bupivacaine—Arrhythmia—Varenicline—nicotine dependence	0.00882	0.00975	CcSEcCtD
Bupivacaine—Mental disorder—Varenicline—nicotine dependence	0.00865	0.00956	CcSEcCtD
Bupivacaine—Malnutrition—Varenicline—nicotine dependence	0.00859	0.0095	CcSEcCtD
Bupivacaine—Erythema—Varenicline—nicotine dependence	0.00859	0.0095	CcSEcCtD
Bupivacaine—Flatulence—Varenicline—nicotine dependence	0.00847	0.00936	CcSEcCtD
Bupivacaine—Back pain—Varenicline—nicotine dependence	0.00831	0.00919	CcSEcCtD
Bupivacaine—Muscle spasms—Varenicline—nicotine dependence	0.00826	0.00914	CcSEcCtD
Bupivacaine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00814	0.0849	CbGpPWpGaD
Bupivacaine—Vision blurred—Varenicline—nicotine dependence	0.0081	0.00896	CcSEcCtD
Bupivacaine—Tremor—Varenicline—nicotine dependence	0.00805	0.0089	CcSEcCtD
Bupivacaine—Anaemia—Varenicline—nicotine dependence	0.00794	0.00878	CcSEcCtD
Bupivacaine—Agitation—Varenicline—nicotine dependence	0.0079	0.00873	CcSEcCtD
Bupivacaine—Angioedema—Varenicline—nicotine dependence	0.00785	0.00868	CcSEcCtD
Bupivacaine—Syncope—Varenicline—nicotine dependence	0.0077	0.00852	CcSEcCtD
Bupivacaine—Palpitations—Varenicline—nicotine dependence	0.00759	0.0084	CcSEcCtD
Bupivacaine—Loss of consciousness—Varenicline—nicotine dependence	0.00755	0.00835	CcSEcCtD
Bupivacaine—Cough—Varenicline—nicotine dependence	0.0075	0.00829	CcSEcCtD
Bupivacaine—Convulsion—Varenicline—nicotine dependence	0.00744	0.00823	CcSEcCtD
Bupivacaine—Hypertension—Varenicline—nicotine dependence	0.00742	0.0082	CcSEcCtD
Bupivacaine—Arthralgia—Varenicline—nicotine dependence	0.00731	0.00809	CcSEcCtD
Bupivacaine—Anxiety—Varenicline—nicotine dependence	0.00729	0.00806	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00726	0.00803	CcSEcCtD
Bupivacaine—Oedema—Varenicline—nicotine dependence	0.00701	0.00776	CcSEcCtD
Bupivacaine—Infection—Varenicline—nicotine dependence	0.00697	0.00771	CcSEcCtD
Bupivacaine—Shock—Varenicline—nicotine dependence	0.0069	0.00763	CcSEcCtD
Bupivacaine—Nervous system disorder—Varenicline—nicotine dependence	0.00688	0.00761	CcSEcCtD
Bupivacaine—Tachycardia—Varenicline—nicotine dependence	0.00684	0.00757	CcSEcCtD
Bupivacaine—Skin disorder—Varenicline—nicotine dependence	0.00681	0.00753	CcSEcCtD
Bupivacaine—Hyperhidrosis—Varenicline—nicotine dependence	0.00678	0.0075	CcSEcCtD
Bupivacaine—Hypotension—Varenicline—nicotine dependence	0.00655	0.00725	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00639	0.00707	CcSEcCtD
Bupivacaine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00635	0.0662	CbGpPWpGaD
Bupivacaine—Insomnia—Varenicline—nicotine dependence	0.00634	0.00701	CcSEcCtD
Bupivacaine—Dyspnoea—Varenicline—nicotine dependence	0.00625	0.00691	CcSEcCtD
Bupivacaine—Somnolence—Varenicline—nicotine dependence	0.00623	0.00689	CcSEcCtD
Bupivacaine—Dyspepsia—Varenicline—nicotine dependence	0.00617	0.00683	CcSEcCtD
Bupivacaine—Decreased appetite—Varenicline—nicotine dependence	0.0061	0.00674	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00605	0.0067	CcSEcCtD
Bupivacaine—Constipation—Varenicline—nicotine dependence	0.006	0.00663	CcSEcCtD
Bupivacaine—Pain—Varenicline—nicotine dependence	0.006	0.00663	CcSEcCtD
Bupivacaine—Feeling abnormal—Varenicline—nicotine dependence	0.00578	0.00639	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00573	0.00634	CcSEcCtD
Bupivacaine—Urticaria—Varenicline—nicotine dependence	0.00557	0.00616	CcSEcCtD
Bupivacaine—Abdominal pain—Varenicline—nicotine dependence	0.00554	0.00613	CcSEcCtD
Bupivacaine—Body temperature increased—Varenicline—nicotine dependence	0.00554	0.00613	CcSEcCtD
Bupivacaine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00548	0.0572	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Varenicline—nicotine dependence	0.00517	0.00571	CcSEcCtD
Bupivacaine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00504	0.0526	CbGpPWpGaD
Bupivacaine—Asthenia—Varenicline—nicotine dependence	0.00503	0.00556	CcSEcCtD
Bupivacaine—Pruritus—Varenicline—nicotine dependence	0.00496	0.00549	CcSEcCtD
Bupivacaine—Diarrhoea—Varenicline—nicotine dependence	0.0048	0.00531	CcSEcCtD
Bupivacaine—Dizziness—Varenicline—nicotine dependence	0.00464	0.00513	CcSEcCtD
Bupivacaine—Vomiting—Varenicline—nicotine dependence	0.00446	0.00493	CcSEcCtD
Bupivacaine—Headache—Varenicline—nicotine dependence	0.00439	0.00486	CcSEcCtD
Bupivacaine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00427	0.0446	CbGpPWpGaD
Bupivacaine—Nausea—Varenicline—nicotine dependence	0.00416	0.00461	CcSEcCtD
Bupivacaine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0033	0.0344	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00296	0.0309	CbGpPWpGaD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00228	0.0237	CbGpPWpGaD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00225	0.0234	CbGpPWpGaD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00209	0.0218	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00207	0.0216	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00192	0.02	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00185	0.0192	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00177	0.0185	CbGpPWpGaD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00175	0.0183	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0017	0.0177	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00168	0.0175	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00164	0.0171	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00152	0.0159	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00144	0.015	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00138	0.0144	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00137	0.0143	CbGpPWpGaD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00135	0.0141	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—FGD1—nicotine dependence	0.00131	0.0137	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—OPRM1—nicotine dependence	0.00125	0.013	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—FGD1—nicotine dependence	0.00119	0.0124	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00119	0.0124	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00111	0.0116	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00104	0.0108	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000981	0.0102	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000967	0.0101	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000957	0.00998	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—DRD2—nicotine dependence	0.000904	0.00942	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000902	0.0094	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TAS2R16—nicotine dependence	0.000899	0.00937	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00089	0.00928	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000811	0.00845	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000764	0.00797	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000754	0.00786	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000706	0.00736	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGD1—nicotine dependence	0.000705	0.00735	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—OPRM1—nicotine dependence	0.000641	0.00669	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000626	0.00652	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKR1B10—nicotine dependence	0.000623	0.0065	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00059	0.00615	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000582	0.00606	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—DRD2—nicotine dependence	0.000511	0.00532	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—DRD2—nicotine dependence	0.000464	0.00484	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—WASF2—nicotine dependence	0.000439	0.00458	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—WASF1—nicotine dependence	0.000421	0.00439	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—OPRM1—nicotine dependence	0.000379	0.00395	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—DRD2—nicotine dependence	0.000274	0.00286	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000168	0.00175	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000154	0.00161	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000131	0.00136	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000101	0.00105	CbGpPWpGaD
